BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 221 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $361 | +0.6% | 51 | 0.0% | 0.00% | – |
| Q2 2023 | $359 | -15.5% | 51 | 0.0% | 0.00% | – |
| Q1 2023 | $425 | -27.4% | 51 | 0.0% | 0.00% | – |
| Q4 2022 | $585 | -41.5% | 51 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 51 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | – | 51 | +628.6% | 0.00% | – |
| Q3 2021 | $0 | – | 7 | +40.0% | 0.00% | – |
| Q2 2021 | $0 | – | 5 | 0.0% | 0.00% | – |
| Q1 2021 | $0 | – | 5 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DG Capital Management, LLC | 1,186,726 | $4,076,000 | 2.45% |
| Sarissa Capital Management LP | 4,861,000 | $16,697,000 | 1.97% |
| Ghost Tree Capital, LLC | 1,950,000 | $6,698,000 | 1.94% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,525,857 | $8,676,000 | 1.14% |
| Eversept Partners, LP | 1,143,211 | $3,926,930 | 0.87% |
| DAFNA Capital Management LLC | 749,051 | $2,573,000 | 0.84% |
| KNOTT DAVID M | 397,361 | $1,365,000 | 0.80% |
| Parkman Healthcare Partners LLC | 800,740 | $2,751,000 | 0.73% |
| ACUTA CAPITAL PARTNERS, LLC | 660,000 | $2,267,000 | 0.62% |
| Formidable Asset Management, LLC | 578,200 | $1,949,000 | 0.57% |